Viking Therapeutics (NASDAQ:VKTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viking Therapeutics Stock (NASDAQ: VKTX) stock price, news, charts, stock research, profile.

Open	$71.37
Close	$72.54
Volume / Avg.	3.42M / 3.34M
Day Range	$70.57 - $74.06
52 Wk Range	9.25 - 99.41
Market Cap	$8.13B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	17.35%
Days to Cover	6.4

Recent News

UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition

Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised concerns over the Catalent acquisition.

Vandana Singh

Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?

Viking Therapeutics (VKTX) set to report Q3 earnings amid high expectations, thanks to promising weight-loss drug candidate. Stock up 240% YTD.

Surbhi Jain

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$71.37
Close	$72.54
Volume / Avg.	3.42M / 3.34M
Day Range	$70.57 - $74.06
52 Wk Range	9.25 - 99.41
Market Cap	$8.13B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	17.35%
Days to Cover	6.4

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viking Therapeutics (VKTX) stock?

You can purchase shares of Viking Therapeutics (NASDAQ:VKTX) through any online brokerage.

View our list of the best stock brokerages

Who are Viking Therapeutics (VKTX) competitors?

Other companies in Viking Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Exact Sciences (NASDAQ:EXAS) and Sarepta Therapeutics (NASDAQ:SRPT).

What is the forecast, or price target, for Viking Therapeutics (VKTX) stock?

Viking Therapeutics has a consensus price target of $79.87.

What is the current price for Viking Therapeutics (VKTX)?

The stock price for Viking Therapeutics (NASDAQ: VKTX) is $72.99 last updated October 31, 2024 at 7:56 PM EDT.

Does Viking Therapeutics (VKTX) pay a dividend?

There are no upcoming dividends for Viking Therapeutics.

When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?

Viking Therapeutics’s Q3 earnings are confirmed for Wednesday, October 23, 2024.

Is Viking Therapeutics (VKTX) going to split?

There is no upcoming split for Viking Therapeutics.

What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Viking Therapeutics

Viking Therapeutics (VKTX) Forecast